Breaking News

NATI

National Instruments

03/21/23 Morgan Stanley: Emerson Electric upgraded to Overweight from Equal Weight at Morgan Stanley

03/06/23 UBS: Emerson Electric upgraded to Buy from Neutral at UBS

02/01/23 Baird: National Instruments downgraded to Neutral from Outperform at Baird

01/18/23 Baird: Aspen Technology price target lowered to $224 from $242 at Baird

Clear This Search Refresh Search

Tuesday Show Full Stories X To view all stories in expanded form, please subscribe. Get Free Trial Send Info
Upgrade	Emerson Electric upgraded to Overweight from Equal Weight at Morgan Stanley » 04:48 03/21/23 03/21 04:48 03/21/23 04:48 EMR Emerson Electric $82.24 / +1.41 (+1.74%) , NATI National Instruments $50.67 / +0.13 (+0.26%) Morgan Stanley upgraded… Morgan Stanley upgraded Emerson Electric (EMR) to Overweight from Equal Weight with a price target of $96, up from $95. The stock's risk/reward is among the best in the sector with the National Instruments (NATI) resolution potentially being a "win-win as management lands an accretive deal or establishes its discipline," the analyst tells investors in a research note. The firm says Emerson's fundamentals are accelerating, particularly with liquified natural gas and hydrogen. It sees an attractive risk/reward at current share levels. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options NATI EMR NATI National Instruments $50.67 / +0.13 (+0.26%) 03/06/23 National Instruments acquires SET GmbH, terms undisclosed 01/17/23 National Instruments confirms receipt of acquisition proposal from Emerson EMR Emerson Electric $82.24 / +1.41 (+1.74%) 03/14/23 Emerson Electric selected to automate photovoltaic project in New Zealand 03/13/23 Emerson selected to automate Golden Triangle Polymers facility 01/23/23 Emerson Electric issues statement regarding National Instruments proposal 01/17/23 National Instruments reiterates commitment to strategic review process EMR NATI EMR Emerson Electric $82.24 / +1.41 (+1.74%) 03/06/23 UBS Emerson Electric upgraded to Buy from Neutral at UBS 02/21/23 TD Cowen Emerson Electric price target lowered to $105 from $115 at Cowen 02/14/23 Argus Argus cuts Emerson Electric to Hold, sees 'problematic' recent trends 02/14/23 Argus Emerson Electric downgraded to Hold from Buy at Argus NATI National Instruments $50.67 / +0.13 (+0.26%) 02/01/23 Baird National Instruments downgraded to Neutral from Outperform at Baird 01/18/23 Baird Aspen Technology price target lowered to $224 from $242 at Baird 01/17/23 Deutsche Bank Emerson makes hostile bid for National Instruments, says Deutsche Bank NATI EMR NATI National Instruments $50.67 / +0.13 (+0.26%) 01/31/23 National Instruments sees Q1 adjusted EPS 48c-62c, consensus 47c 01/31/23 National Instruments reports Q4 adjusted EPS 63c, consensus 64c 10/27/22 National Instruments sees Q4 non-GAP EPS 54c-68c, consensus 76c 10/27/22 National Instruments reports Q3 non-GAAP EPS 53c, consensus 53c EMR Emerson Electric $82.24 / +1.41 (+1.74%) 02/08/23 Emerson Electric backs FY23 adjusted EPS view $4.00-$4.15, consensus $4.08 02/08/23 Emerson Electric sees Q2 adjusted EPS 95c-$1.00, consensus $1.00 02/08/23 Emerson Electric reports Q1 adjusted EPS 78c, consensus 88c 10/31/22 Emerson Electric sees FY23 adjusted EPS $4.00-$4.15, consensus $5.08 EMR EMR Emerson Electric $82.24 / +1.41 (+1.74%) 10/31/22 Blackstone to buy 55% stake in Emerson unit in $14B deal, WSJ reports 10/04/22 Blackstone in talks to acquire select Emerson assets, Bloomberg says 10/04/22 Blackstone in talks to acquire select Emerson assets, Bloomberg says NATI EMR NATI National Instruments $50.67 / +0.13 (+0.26%) 01/17/23 What You Missed On Wall Street This Morning 01/13/23 What You Missed On Wall Street On Friday EMR Emerson Electric $82.24 / +1.41 (+1.74%) 03/06/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/08/23 What You Missed On Wall Street This Morning 02/08/23 Fly Intel: Pre-market Movers 01/17/23 What You Missed On Wall Street On Tuesday NATI NATI National Instruments $50.67 / +0.13 (+0.26%) 03/17/23 National Instruments put volume heavy and directionally bearish 03/01/23 National Instruments call volume above normal and directionally bullish

Over a week ago
Options	National Instruments put volume heavy and directionally bearish » 12:35 03/17/23 03/17 12:35 03/17/23 12:35 NATI National Instruments $50.42 / +0.04 (+0.08%) Bearish flow noted in… Bearish flow noted in National Instruments with 4,537 puts trading, or 4x expected. Most active are Apr-23 42.5 puts and Apr-23 47.5 puts, with total volume in those strikes near 3,700 contracts. The Put/Call Ratio is 7.16, while ATM IV is up nearly 3 points on the day. Earnings are expected on April 27th. ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options NATI National Instruments $50.42 / +0.04 (+0.08%) 03/06/23 National Instruments acquires SET GmbH, terms undisclosed 01/23/23 Emerson Electric issues statement regarding National Instruments proposal 01/17/23 National Instruments reiterates commitment to strategic review process 01/17/23 National Instruments confirms receipt of acquisition proposal from Emerson NATI National Instruments $50.42 / +0.04 (+0.08%) 03/06/23 UBS Emerson Electric upgraded to Buy from Neutral at UBS 02/01/23 Baird National Instruments downgraded to Neutral from Outperform at Baird 01/18/23 Baird Aspen Technology price target lowered to $224 from $242 at Baird 01/17/23 Deutsche Bank Emerson makes hostile bid for National Instruments, says Deutsche Bank NATI National Instruments $50.42 / +0.04 (+0.08%) 01/31/23 National Instruments sees Q1 adjusted EPS 48c-62c, consensus 47c 01/31/23 National Instruments reports Q4 adjusted EPS 63c, consensus 64c 10/27/22 National Instruments sees Q4 non-GAP EPS 54c-68c, consensus 76c 10/27/22 National Instruments reports Q3 non-GAAP EPS 53c, consensus 53c NATI National Instruments $50.42 / +0.04 (+0.08%) 03/06/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 01/17/23 What You Missed On Wall Street On Tuesday 01/17/23 What You Missed On Wall Street This Morning 01/13/23 What You Missed On Wall Street On Friday NATI National Instruments $50.42 / +0.04 (+0.08%) 03/01/23 National Instruments call volume above normal and directionally bullish
On The Fly	Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations » 10:30 03/06/23 03/06 10:30 03/06/23 10:30 MNST Monster Beverage $103.05 / +1.06 (+1.04%) , HCP HashiCorp $33.51 / +1.85 (+5.84%) , EMR Emerson Electric $87.74 / +2.2 (+2.57%) , NATI National Instruments $51.24 / + (+0.00%) , MTH Meritage Homes $111.36 / +1.07 (+0.97%) , VIR Vir Biotechnology $23.11 / +0.275 (+1.20%) , WEN Wendy's $21.76 / -0.17 (-0.78%) , RH RH $291.49 / -5.8 (-1.95%) , SI Silvergate Capital $6.15 / +0.38 (+6.59%) , DHI D.R. Horton $92.48 / -0.27 (-0.29%) , KBH KB Home $35.55 / -0.215 (-0.60%) , HR Healthcare Realty Trust $19.24 / -0.21 (-1.08%) , AAPL Apple $154.73 / +3.65 (+2.42%) , BMY Bristol-Myers $69.31 / +0.01 (+0.01%) , PFE Pfizer $41.13 / -0.025 (-0.06%) , LLY Eli Lilly $317.50 / -0.98 (-0.31%) , MRK Merck $108.10 / +1.23 (+1.15%) Want to get stock-moving… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options WEN VIR SI RH PFE NATI MTH MRK MNST LLY KBH HR HCP EMR DHI BMY AAPL WEN Wendy's $21.76 / -0.17 (-0.78%) 03/03/23 Trian Fund cuts Wendy's stake to 17.85% from 19.52% 03/01/23 Wendy's sees FY23 CapEx $75M-$85M 03/01/23 Wendy's announces plan to redesign organizational structure 03/01/23 Wendy's reports Q4 U.S. systemwide sales growth of 7.2% VIR Vir Biotechnology $23.11 / +0.275 (+1.20%) 02/23/23 Vir Biotechnology shares fall over 5% after missing quarterly estimates 02/22/23 Vir Biotechnology announces final draft guidance on sotrovimab from U.K.'s NICE 02/16/23 Vir Biotechnology appoints Sung Lee as Chief Financial Officer 02/13/23 Vir Biotechnology announces amended collaboration pact with GSK SI Silvergate Capital $6.15 / +0.38 (+6.59%) 03/06/23 Silvergate Capital falls -9.6% 03/06/23 Silvergate falls after discontinuing Silvergate Exchange Network 03/03/23 Silvergate Capital falls -6.4% 03/02/23 Silvergate Capital falls -44.7% RH RH $291.49 / -5.8 (-1.95%) 02/03/23 RH says certain financial statements 'should no longer be relied upon' 02/03/23 RH sees FY22 revenue growth at low end of prior range of (3.5%)-(4.5%) 12/08/22 RH says Q3 gross margin contracted 50bps 12/08/22 RH to acquire Dmitriy & Co PFE Pfizer $41.13 / -0.025 (-0.06%) 03/02/23 Cue Health announces new COVID-19 awareness collaboration with Pfizer 02/28/23 Pfizer gets positive FDA AdCom votes for PF-06928316 02/24/23 Pfizer treatment of pulmonary arterial hypertension gets FDA orphan designation 02/22/23 Pfizer's elranatamab receives FDA and EMA filing acceptance NATI National Instruments $51.24 / + (+0.00%) 03/06/23 National Instruments acquires SET GmbH, terms undisclosed MTH Meritage Homes $111.36 / +1.07 (+0.97%) 02/16/23 Meritage Homes initiates quarterly dividend of 27c per share 02/01/23 Meritage Homes reports Q4 EPS $7.09, consensus $7.00 10/26/22 Meritage Homes sees Q4 home closings 4,300-4,700 09/29/22 Meritage Homes releases second annual ESG report MRK Merck $108.10 / +1.23 (+1.15%) 03/06/23 Merck: FDA approves IM route of administration for MMRV family of vaccines 03/02/23 Illumina and Myriad Genetics partner for HRD testing in the U.S. 03/02/23 AstraZeneca says FDA to convene AdCom meeting on sNDA for Lynparza in mCRPC 03/01/23 BeyondSpring enrolls first patient in study of Plinabulin, Keytruda, Docetaxel MNST Monster Beverage $103.05 / +1.06 (+1.04%) 02/28/23 Monster Beverage announces 2-for-1 split, effective March 28 11/03/22 Monster Beverage announces new $500M share repurchase program 10/27/22 MSG Sports, MSG Entertainment enter marketing partnership with Monster Energy 10/10/22 VPX Sports, maker of Bang Energy drinks, seeks Chapter 11 bankruptcy protection LLY Eli Lilly $317.50 / -0.98 (-0.31%) 03/03/23 Eli Lilly says FDA broadens indication for Verzenio 03/01/23 Eli Lilly cuts insulin prices by 70%, caps out of pocket costs 02/23/23 Nektar reports Phase 2 data on rezpegaldesleukin in lupus 02/13/23 Eli Lilly to supply API for insulin at reduced price to IABL KBH KB Home $35.55 / -0.215 (-0.60%) 01/11/23 KB Home falls 5% to $34.20 after Q4 earnings miss and guidance 01/11/23 KB Home sees 2023 housing revenue at $5.0B-$6.0B vs. $6.88B in 2022 01/11/23 KB Home sees Q1 housing revenue at $1.25B-$1.40B 01/11/23 KB Home reports Q4 gross orders down 47% HR Healthcare Realty Trust $19.24 / -0.21 (-1.08%) 01/31/23 Healthcare Realty Trust completes $112.M in asset sales to fund special dividend HCP HashiCorp $33.51 / +1.85 (+5.84%) 02/23/23 HashiCorp exec sells $1.16M in common stock 02/01/23 PowerSchool appoints Paul Brook as CCO 12/07/22 HashiCorp jumps 10% to $29.43 after Q3 earnings beat and guidance raise 10/19/22 Intel announces new cloud collaboration with HashiCorp EMR Emerson Electric $87.74 / +2.2 (+2.57%) 01/23/23 Emerson Electric issues statement regarding National Instruments proposal 01/17/23 National Instruments reiterates commitment to strategic review process 01/17/23 National Instruments confirms receipt of acquisition proposal from Emerson 01/17/23 Emerson Electric 'disappointed' National Instruments chose to announce review DHI D.R. Horton $92.48 / -0.27 (-0.29%) 02/13/23 Soros Fund buys Horizon Therapeutics, exits BNY Mellon in Q4 01/24/23 D.R. Horton saw 'slight' improvement in cancellation rate in January 01/24/23 D.R. Horton: Goal is to generate FY23 revenue slightly higher than FY22 12/15/22 D.R. Horton acquires homebuilding operations of Riggins Custom Homes BMY Bristol-Myers $69.31 / +0.01 (+0.01%) 03/03/23 Bristol-Myers receives EC approval of Reblozyl 03/02/23 Bristol-Myers and Johnson & Johnson launch Phase 3 trial of milvexian 02/28/23 Bristol-Myers: FDA accepts sBLA for Opdivo 02/17/23 Bristol-Myers announces three-year results from Phase 3 CheckMate-274 trial AAPL Apple $154.73 / +3.65 (+2.42%) 02/28/23 Globalstar spikes 10% after disclosing $252M loan from Apple 02/22/23 Apple prepares to allow outside app stores or 'sideloading,' Bloomberg reports 02/16/23 T-Mobile announces launch of MLS Season Pass on Apple TV app 02/14/23 Berkshire added more of top-holding Apple, Paramount in Q4 MNST HCP EMR NATI MTH VIR WEN RH SI DHI KBH HR AAPL BMY PFE LLY MRK MNST Monster Beverage $103.05 / +1.06 (+1.04%) 03/06/23 Redburn Monster Beverage upgraded to Buy from Neutral at Redburn 03/01/23 BMO Capital Monster Beverage price target raised to $105 from $97 at BMO Capital 03/01/23 Truist Monster Beverage price target raised to $120 from $100 at Truist 03/01/23 Citi Monster Beverage price target lowered to $118 from $121 at Citi HCP HashiCorp $33.51 / +1.85 (+5.84%) 03/06/23 Needham Needham upgrades HashiCorp to Buy on conservative 2023 estimates 03/06/23 Needham HashiCorp upgraded to Buy from Hold at Needham 02/24/23 Scotiabank HashiCorp initiated with a Sector Perform, $34 target at Scotiabank 02/23/23 Scotiabank HashiCorp initiated with a Sector Perform at Scotiabank EMR Emerson Electric $87.74 / +2.2 (+2.57%) 03/06/23 UBS Emerson Electric upgraded to Buy from Neutral at UBS 02/21/23 TD Cowen Emerson Electric price target lowered to $105 from $115 at Cowen 02/14/23 Argus Argus cuts Emerson Electric to Hold, sees 'problematic' recent trends 02/14/23 Argus Emerson Electric downgraded to Hold from Buy at Argus NATI National Instruments $51.24 / + (+0.00%) 02/01/23 Baird National Instruments downgraded to Neutral from Outperform at Baird 01/18/23 Baird Aspen Technology price target lowered to $224 from $242 at Baird 01/17/23 Deutsche Bank Emerson makes hostile bid for National Instruments, says Deutsche Bank MTH Meritage Homes $111.36 / +1.07 (+0.97%) 03/06/23 JPMorgan Meritage Homes upgraded to Overweight from Neutral at JPMorgan 11/22/22 JPMorgan Meritage Homes price target raised to $90 from $78 at JPMorgan 11/14/22 KeyBanc Meritage Homes price target raised to $96 from $87 at KeyBanc 10/10/22 Wedbush Meritage Homes price target lowered to $102 from $130 at Wedbush VIR Vir Biotechnology $23.11 / +0.275 (+1.20%) 03/06/23 H.C. Wainwright Vir Biotechnology price target lowered to $100 from $125 at H.C. Wainwright 03/06/23 JPMorgan Vir Biotechnology upgraded to Overweight from Neutral at JPMorgan 02/21/23 Goldman Sachs Vir Biotechnology upgraded to Buy from Neutral at Goldman Sachs 01/27/23 Morgan Stanley Vir Biotechnology upgraded to Equal Weight from Underweight at Morgan Stanley WEN Wendy's $21.76 / -0.17 (-0.78%) 03/06/23 Northcoast Wendy's downgraded to Neutral at Northcoast on profit headwinds, share risk 03/06/23 Northcoast Wendy's downgraded to Neutral from Buy at Northcoast 01/17/23 Truist Wendy's price target raised to $28 from $27 at Truist 01/16/23 Deutsche Bank Wendy's downgraded to Hold from Buy at Deutsche Bank RH RH $291.49 / -5.8 (-1.95%) 03/06/23 Jefferies RH cut to Hold at Jefferies with luxury housing market 'struggling to stabilize' 03/06/23 Jefferies RH downgraded to Hold from Buy at Jefferies 02/07/23 Barclays Barclays sees a 'reset' in U.S. retail but 'not a recession yet' 02/07/23 Barclays RH assumed with an Equal Weight at Barclays SI Silvergate Capital $6.15 / +0.38 (+6.59%) 03/06/23 Compass Point Silvergate Capital downgraded to Sell from Neutral at Compass Point 03/06/23 Wedbush Wedbush downgrades Silvergate Capital to Underperform, lowers price target to $4 03/06/23 Wedbush Silvergate Capital downgraded to Underperform from Neutral at Wedbush 03/02/23 Goldman Sachs Goldman suspends Silvergate rating on 'insufficient information' DHI D.R. Horton $92.48 / -0.27 (-0.29%) 03/06/23 JPMorgan D.R. Horton downgraded to Neutral from Overweight at JPMorgan 01/25/23 BTIG D.R. Horton price target raised to $108 from $101 at BTIG 01/25/23 JMP Securities D.R. Horton price target raised to $115 from $95 at JMP Securities 01/25/23 Wedbush Wedbush downgrades D.R. Horton to Neutral, lowers price target to $96 KBH KB Home $35.55 / -0.215 (-0.60%) 03/06/23 JPMorgan KB Home downgraded to Underweight from Overweight at JPMorgan 01/13/23 BTIG KB Home earnings miss driven by fewer deliveries, says BTIG 01/13/23 RBC Capital KB Home downgraded to Sector Perform from Outperform at RBC Capital 01/12/23 UBS KB Home price target lowered to $45 from $48 at UBS HR Healthcare Realty Trust $19.24 / -0.21 (-1.08%) 03/06/23 Credit Suisse Healthcare Realty Trust downgraded to Neutral from Outperform at Credit Suisse 01/30/23 Citi Citi opens 'Catalyst Watches' into REITs, lodging earnings reports 12/14/22 Citi Healthcare Realty Trust downgraded to Neutral from Buy at Citi 11/10/22 Barclays Healthcare Realty Trust price target lowered to $28 from $33 at Barclays AAPL Apple $154.73 / +3.65 (+2.42%) 03/06/23 BofA Apple App Store revenue growth 'still muted' in fiscal Q2-to-date, says BofA 03/05/23 Goldman Sachs Apple initiated with a Buy at Goldman Sachs 03/03/23 Barclays Google facing query share loss for first time ever, says Barclays 03/03/23 Morgan Stanley Morgan Stanley sees catalysts for top pick Apple, ups price target BMY Bristol-Myers $69.31 / +0.01 (+0.01%) 03/06/23 Jefferies Jefferies starts 'optically cheap' Bristol-Myers at Hold on structural concerns 03/06/23 Jefferies Bristol-Myers initiated with a Hold at Jefferies 01/19/23 Piper Sandler Amgen price target cut at Piper on lower Otezla estimates 01/17/23 Cantor Fitzgerald Bristol-Myers initiated with an Overweight at Cantor Fitzgerald PFE Pfizer $41.13 / -0.025 (-0.06%) 03/06/23 Jefferies Jefferies starts Pfizer with a Hold on lack of visibility 03/06/23 Jefferies Pfizer initiated with a Hold at Jefferies 03/03/23 SVB Securities SVB says Pfizer could create value for holders with Seagen bid up to $253 02/28/23 Oppenheimer Seagen price target raised to $210 from $180 at Oppenheimer LLY Eli Lilly $317.50 / -0.98 (-0.31%) 03/06/23 Jefferies Jefferies starts 'priced to perfection' Eli Lilly with a Hold 03/06/23 Jefferies Eli Lilly initiated with a Hold at Jefferies 03/02/23 Morgan Stanley Novo Nordisk named 'Catalyst Driven Idea' at Morgan Stanley 02/24/23 Jefferies Nektar downgraded to Underperform from Hold at Jefferies MRK Merck $108.10 / +1.23 (+1.15%) 03/06/23 Jefferies Merck initiated with a Buy at Jefferies 02/23/23 JPMorgan Merck shares positioned for further upside, says JPMorgan 02/22/23 Wolfe Research Wolfe upgrades Merck with pipeline 'big enough to matter' WEN VIR SI RH PFE NATI MTH MRK MNST LLY KBH HR HCP EMR DHI BMY AAPL WEN Wendy's $21.76 / -0.17 (-0.78%) 03/01/23 Wendy's sees FY23 adjusted EPS 95c-$1.00, consensus $1.00 03/01/23 Wendy's reports Q4 adjusted EPS 22c, consensus 20c 02/28/23 Notable companies reporting before tomorrow's open VIR Vir Biotechnology $23.11 / +0.275 (+1.20%) 02/23/23 Vir Biotechnology reports Q4 EPS (76c), consensus (39c) 11/03/22 Vir Biotechnology reports Q3 EPS $1.30, consensus (21c) SI Silvergate Capital $6.15 / +0.38 (+6.59%) 01/17/23 Silvergate Capital reports Q4 adjusted EPS 48c, consensus 81c 10/18/22 Silvergate Capital reports Q3 EPS $1.28, consensus $1.38 RH RH $291.49 / -5.8 (-1.95%) 12/08/22 RH narrow FY22 revenue growth view to down 4.5% to down 3.5% 12/08/22 RH reports Q3 EPS $5.67, consensus $4.70 12/08/22 Notable companies reporting after market close 09/08/22 RH sees Q3 revenue down 18% to down 15% PFE Pfizer $41.13 / -0.025 (-0.06%) 01/31/23 Pfizer sees FY23 adjusted EPS $3.25-$3.45, consensus $4.44 01/31/23 Pfizer reports Q4 adjusted EPS $1.14, consensus $1.05 01/30/23 Notable companies reporting before tomorrow's open NATI National Instruments $51.24 / + (+0.00%) 01/31/23 National Instruments sees Q1 adjusted EPS 48c-62c, consensus 47c 01/31/23 National Instruments reports Q4 adjusted EPS 63c, consensus 64c 10/27/22 National Instruments sees Q4 non-GAP EPS 54c-68c, consensus 76c 10/27/22 National Instruments reports Q3 non-GAAP EPS 53c, consensus 53c MTH Meritage Homes $111.36 / +1.07 (+0.97%) 10/26/22 Meritage Homes sees Q4 adjusted EPS $6.50-$7.40, consensus $6.92 10/26/22 Meritage Homes reports Q3 EPS $7.10, consensus $6.45 MRK Merck $108.10 / +1.23 (+1.15%) 02/28/23 NGM Biopharmaceuticals reports Q4 EPS (45c), consensus (51c) 02/02/23 Merck sees FY23 adjusted EPS $6.80-$6.95, consensus $7.36 02/02/23 Merck reports Q4 adjusted EPS $1.62, consensus $1.54 MNST Monster Beverage $103.05 / +1.06 (+1.04%) 02/28/23 Monster Beverage reports Q4 EPS 57c, consensus 63c 02/28/23 Notable companies reporting after market close 11/03/22 Monster Beverage reports Q3 EPS 60c, consensus 59c 11/03/22 Notable companies reporting after market close LLY Eli Lilly $317.50 / -0.98 (-0.31%) 02/02/23 Eli Lilly raises FY23 adjusted EPS view to $8.35-$8.55 from $8.10-$8.30 02/02/23 Eli Lilly reports Q4 adjusted EPS $2.09, consensus $1.78 KBH KB Home $35.55 / -0.215 (-0.60%) 01/11/23 KB Home reports Q4 EPS $2.47, consensus $2.87 09/21/22 KB Home sees Q4 housing revenue $1.95B-$2.05B 09/21/22 KB Home reports Q3 EPS $2.86, consensus $2.67 09/21/22 Notable companies reporting after market close HR Healthcare Realty Trust $19.24 / -0.21 (-1.08%) 03/01/23 Healthcare Realty Trust reports Q4 normalized FFO 42c, consensus 40c 11/09/22 Healthcare Realty Trust reports Q3 normalized FFO 39c, consensus 42c HCP HashiCorp $33.51 / +1.85 (+5.84%) 12/07/22 HashiCorp raises FY23 EPS view to (71c)-(69c) from (97c)-(95c), consensus (96c) 12/07/22 HashiCorp sees Q4 EPS (23c)-(21c), consensus (30c) 12/07/22 HashiCorp reports Q3 EPS (13c), consensus (31c) EMR Emerson Electric $87.74 / +2.2 (+2.57%) 02/08/23 Emerson Electric backs FY23 adjusted EPS view $4.00-$4.15, consensus $4.08 02/08/23 Emerson Electric sees Q2 adjusted EPS 95c-$1.00, consensus $1.00 02/08/23 Emerson Electric reports Q1 adjusted EPS 78c, consensus 88c 10/31/22 Emerson Electric sees FY23 adjusted EPS $4.00-$4.15, consensus $5.08 DHI D.R. Horton $92.48 / -0.27 (-0.29%) 01/24/23 D.R. Horton sees Q2 revenue $6.3B-$6.7B, consensus $6.53B 01/24/23 D.R. Horton reports Q1 EPS $2.76, consensus $2.26 01/23/23 Notable companies reporting before tomorrow's open BMY Bristol-Myers $69.31 / +0.01 (+0.01%) 02/02/23 Bristol-Myers sees FY23 adjusted EPS $7.95-$8.25, consensus $8.00 02/02/23 Bristol-Myers reports Q4 adjusted EPS $1.82, consensus $1.72 02/01/23 Notable companies reporting before tomorrow's open AAPL Apple $154.73 / +3.65 (+2.42%) 02/02/23 Apple reports Q1 EPS $1.88, consensus $1.94 02/02/23 Notable companies reporting after market close 10/27/22 Apple reports Q4 EPS $1.29, consensus $1.17 10/27/22 Notable companies reporting after market close VIR SI PFE MRK MNST LLY HCP EMR DHI BMY AAPL VIR Vir Biotechnology $23.11 / +0.275 (+1.20%) 09/16/22 WHO panel recommends against GSK, Regeneron COVID drugs, Bloomberg reports SI Silvergate Capital $6.15 / +0.38 (+6.59%) 03/03/23 Silvergate Capital suspending Silvergate exchange network, Bloomberg says 03/03/23 FHLB says Silvergate advances 'fully repaid,' American Banker reports 03/02/23 Coinbase, Galaxy drop Silvergate after going concern filing, Reuters reports 02/16/23 Binance had secret access to U.S. partner account at Silvergate, Reuters says PFE Pfizer $41.13 / -0.025 (-0.06%) 02/28/23 FDA advisors back safety of Pfizer RSV vaccine 02/27/23 Pfizer in talks to buy Seagen in deal that may be valued at over $30B, WSJ says 02/04/23 Pfizer stock a buy as company moves beyond COVID, Barron's says 02/01/23 Novavax refuses to refund $700M for COVID shots never delivered, NY Times says MRK Merck $108.10 / +1.23 (+1.15%) 01/13/23 Johnson & Johnson cuts production of Covid-19 vaccine, WSJ reports 01/11/23 Merck, Pfizer rebuff China's efforts to cut Covid drug prices, Bloomberg says 12/30/22 Merck's Covid treatment gets conditional approval in China, Reuters reports MNST Monster Beverage $103.05 / +1.06 (+1.04%) 09/30/22 Jury awards $293M in damages to Monster from rival Bang Energy, Reuters reports LLY Eli Lilly $317.50 / -0.98 (-0.31%) 03/06/23 New diabetes drugs altering how patients are treated, WSJ reports 12/19/22 Eli Lilly's Mounjaro, Trulicity added to FDA shortage list, STATNews reports 10/11/22 New quality issues found at Eli Lilly drug plant, Reuters reports HCP HashiCorp $33.51 / +1.85 (+5.84%) 12/27/22 Changes at Disney, a Stitch Fix deal among The Information's 2023 predictions EMR Emerson Electric $87.74 / +2.2 (+2.57%) 10/31/22 Blackstone to buy 55% stake in Emerson unit in $14B deal, WSJ reports 10/04/22 Blackstone in talks to acquire select Emerson assets, Bloomberg says 10/04/22 Blackstone in talks to acquire select Emerson assets, Bloomberg says DHI D.R. Horton $92.48 / -0.27 (-0.29%) 11/12/22 Housing stocks have rallied, but could start falling again, Barron's says BMY Bristol-Myers $69.31 / +0.01 (+0.01%) 01/04/23 Aurinia worth 'keeping closer eye on' after settlement, Dealreporter says 10/20/22 Drugmakers look to limit Medicare's power to negotiate drug prices, WSJ reports AAPL Apple $154.73 / +3.65 (+2.42%) 03/03/23 Apple executive in charge of cloud initiatives stepping down, Bloomberg reports 03/03/23 Foxconn plans $700M investment in India plant, Bloomberg reports 03/02/23 ESPN looking to be hub of all live sports streaming, CNBC reports 03/02/23 2023 iPhone to be powered by TSMC's 3nm SoC, DigiTimes reports WEN VIR SI RH PFE NATI MTH MRK MNST LLY KBH HCP EMR DHI BMY AAPL WEN Wendy's $21.76 / -0.17 (-0.78%) 03/01/23 Fly Intel: Pre-market Movers VIR Vir Biotechnology $23.11 / +0.275 (+1.20%) 03/06/23 Fly Intel: Pre-market Movers 02/21/23 What You Missed On Wall Street On Tuesday 02/21/23 What You Missed On Wall Street This Morning SI Silvergate Capital $6.15 / +0.38 (+6.59%) 03/03/23 Here's What You Missed in Crypto This Week 03/02/23 What You Missed On Wall Street On Thursday RH RH $291.49 / -5.8 (-1.95%) 02/06/23 What You Missed On Wall Street On Monday 02/06/23 What You Missed On Wall Street This Morning 02/06/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations PFE Pfizer $41.13 / -0.025 (-0.06%) 02/27/23 What You Missed On Wall Street On Monday 02/27/23 What You Missed On Wall Street This Morning 02/27/23 Fly Intel: Pre-market Movers NATI National Instruments $51.24 / + (+0.00%) 01/17/23 What You Missed On Wall Street This Morning 01/13/23 What You Missed On Wall Street On Friday MTH Meritage Homes $111.36 / +1.07 (+0.97%) 09/19/22 What You Missed On Wall Street On Monday 09/19/22 What You Missed On Wall Street This Morning 09/19/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations MRK Merck $108.10 / +1.23 (+1.15%) 02/25/23 Buy/Sell: Wall Street's top 10 stock calls this week 02/23/23 What You Missed On Wall Street On Thursday 02/23/23 What You Missed On Wall Street This Morning MNST Monster Beverage $103.05 / +1.06 (+1.04%) 03/06/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/01/23 What You Missed On Wall Street On Wednesday 03/01/23 What You Missed On Wall Street This Morning 02/28/23 Fly Intel: After-Hours Movers LLY Eli Lilly $317.50 / -0.98 (-0.31%) 02/02/23 What You Missed On Wall Street On Thursday 02/02/23 What You Missed On Wall Street This Morning KBH KB Home $35.55 / -0.215 (-0.60%) 01/13/23 What You Missed On Wall Street This Morning 01/12/23 Fly Intel: Pre-market Movers HCP HashiCorp $33.51 / +1.85 (+5.84%) 02/24/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/13/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 12/08/22 What You Missed On Wall Street On Thursday EMR Emerson Electric $87.74 / +2.2 (+2.57%) 02/08/23 What You Missed On Wall Street This Morning 02/08/23 Fly Intel: Pre-market Movers 01/17/23 What You Missed On Wall Street On Tuesday DHI D.R. Horton $92.48 / -0.27 (-0.29%) 01/24/23 What You Missed On Wall Street On Tuesday 01/24/23 What You Missed On Wall Street This Morning 11/09/22 Fly Intel: Pre-market Movers BMY Bristol-Myers $69.31 / +0.01 (+0.01%) 02/02/23 Fly Intel: Pre-market Movers 01/17/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 11/21/22 Biotech Alert: Searches spiking for these stocks today AAPL Apple $154.73 / +3.65 (+2.42%) 03/03/23 Fly Intel: Pre-market Movers 03/01/23 #SocialStocks: Meta leverages artificial intelligence throughout subsidiaries 03/09/23 Pharmaceuticals 03/09/23 Biopharma/Biotech 03/15/23 Healthcare/Neuroscience 03/06/23 Technology, Media & Telecom Conference 03/07/23 43rd Annual Healthcare Conference 03/17/23 2023 AAD Annual Meeting 05/12/23 2023 Real Estate Summit 03/09/23 HashiCorp - HCP 04/27/23 Bristol-Myers - BMY 04/27/23 Merck - MRK 04/27/23 Eli Lilly - LLY 06/16/23 PDUFA Date for CAMZYOS 03/06/23 Merck 03/10/23 Apple, Inc. 03/14/23 HashiCorp WEN SI RH PFE NATI MRK MNST LLY KBH HCP DHI BMY AAPL WEN Wendy's $21.76 / -0.17 (-0.78%) 09/12/22 Wendy's call buyer realizes 30% same-day gains SI Silvergate Capital $6.15 / +0.38 (+6.59%) 03/06/23 Unusually active option classes on open March 6th 03/06/23 Notable open interest changes for March 6th 03/03/23 Notable open interest changes for March 3rd 02/15/23 Silvergate Capital Corp call volume above normal and directionally bullish RH RH $291.49 / -5.8 (-1.95%) 02/08/23 Largest borrow rate increases among liquid names 12/08/22 Restoration Hardware options imply 7.8% move in share price post-earnings 10/24/22 Restoration Hardware put volume heavy and directionally bearish 09/08/22 Restoration Hardware options imply 7.3% move in share price post-earnings PFE Pfizer $41.13 / -0.025 (-0.06%) 01/31/23 Unusually active option classes on open January 31st 01/11/23 Largest borrow rate increases among liquid names 01/10/23 Unusually active option classes on open January 10th 11/14/22 Pfizer call volume above normal and directionally bullish NATI National Instruments $51.24 / + (+0.00%) 03/01/23 National Instruments call volume above normal and directionally bullish MRK Merck $108.10 / +1.23 (+1.15%) 01/10/23 Largest borrow rate increases among liquid names 12/07/22 Largest borrow rate increases among liquid names 11/14/22 Early notable gainers among liquid option names on November 14th 10/10/22 Early notable gainers among liquid option names on October 10th MNST Monster Beverage $103.05 / +1.06 (+1.04%) 03/02/23 Early notable gainers among liquid option names on March 2nd LLY Eli Lilly $317.50 / -0.98 (-0.31%) 11/01/22 Unusually active option classes on open November 1st 10/03/22 Eli Lilly And Co put volume heavy and directionally bearish 09/28/22 Early notable gainers among liquid option names on September 28th 09/28/22 Unusually active option classes on open September 28th KBH KB Home $35.55 / -0.215 (-0.60%) 02/09/23 Unusually active option classes on open February 9th 02/08/23 KB Home put volume heavy and directionally bearish 01/11/23 KB Home options imply 4.2% move in share price post-earnings 12/07/22 KB Home put volume heavy and directionally bearish HCP HashiCorp $33.51 / +1.85 (+5.84%) 12/07/22 Hashicorp options imply 11.3% move in share price post-earnings DHI D.R. Horton $92.48 / -0.27 (-0.29%) 02/17/23 D R Horton put volume heavy and directionally bearish 02/03/23 D R Horton put volume heavy and directionally bearish 01/19/23 D R Horton put volume heavy and directionally bearish 11/09/22 Early notable gainers among liquid option names on November 9th BMY Bristol-Myers $69.31 / +0.01 (+0.01%) 02/24/23 Bristol Myers Squibb put volume heavy and directionally bearish 09/29/22 Early notable gainers among liquid option names on September 29th 09/12/22 Early notable gainers among liquid option names on September 12th 09/12/22 Unusually active option classes on open September 12th AAPL Apple $154.73 / +3.65 (+2.42%) 03/02/23 Notable open interest changes for March 2nd 03/01/23 Notable open interest changes for March 1st 02/28/23 Notable open interest changes for February 28th
Hot Stocks	National Instruments acquires SET GmbH, terms undisclosed » 09:12 03/06/23 03/06 09:12 03/06/23 09:12 NATI National Instruments $51.24 / +0.63 (+1.24%) NI announced the… NI announced the acquisition of SET GmbH, long-standing experts in aerospace and defense test system development and recent innovators in power semiconductor reliability test. Together, the companies will reduce time to market for critical, highly differentiated solutions and accelerate semiconductor-to-transportation supply-chain convergence with power electronic materials such as silicon carbide, or SiC, and gallium nitrite, or GaN. ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options NATI National Instruments $51.24 / +0.63 (+1.24%) 01/23/23 Emerson Electric issues statement regarding National Instruments proposal 01/17/23 National Instruments reiterates commitment to strategic review process 01/17/23 National Instruments confirms receipt of acquisition proposal from Emerson 01/17/23 Emerson Electric 'disappointed' National Instruments chose to announce review NATI National Instruments $51.24 / +0.63 (+1.24%) 03/06/23 UBS Emerson Electric upgraded to Buy from Neutral at UBS 02/01/23 Baird National Instruments downgraded to Neutral from Outperform at Baird 01/18/23 Baird Aspen Technology price target lowered to $224 from $242 at Baird 01/17/23 Deutsche Bank Emerson makes hostile bid for National Instruments, says Deutsche Bank NATI National Instruments $51.24 / +0.63 (+1.24%) 01/31/23 National Instruments sees Q1 adjusted EPS 48c-62c, consensus 47c 01/31/23 National Instruments reports Q4 adjusted EPS 63c, consensus 64c 10/27/22 National Instruments sees Q4 non-GAP EPS 54c-68c, consensus 76c 10/27/22 National Instruments reports Q3 non-GAAP EPS 53c, consensus 53c NATI National Instruments $51.24 / +0.63 (+1.24%) 01/17/23 What You Missed On Wall Street On Tuesday 01/17/23 What You Missed On Wall Street This Morning 01/13/23 What You Missed On Wall Street On Friday 01/13/23 What You Missed On Wall Street This Morning 03/06/23 Technology, Media & Telecom Conference NATI National Instruments $51.24 / +0.63 (+1.24%) 03/01/23 National Instruments call volume above normal and directionally bullish
Upgrade	Emerson Electric upgraded to Buy from Neutral at UBS » 05:57 03/06/23 03/06 05:57 03/06/23 05:57 EMR Emerson Electric $85.55 / +1.77 (+2.11%) , NATI National Instruments $51.24 / +0.63 (+1.24%) UBS analyst Chris Snyder… UBS analyst Chris Snyder upgraded Emerson Electric (EMR) to Buy from Neutral with a price target of $97, down from $100, following the January 4 downgrade. The firm finds the recent derating overdone, and while UBS has been critical of a potential National Instruments (NATI) deal, thinks the market-implied $10B value erosion "seems excessive," the analyst tells investors in a research note. Assuming an $8B acquisition of National Instruments, the firm's math suggests Emerson still has $4B incremental dry powder. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options EMR EMR Emerson Electric $85.55 / +1.77 (+2.11%) 01/23/23 Emerson Electric issues statement regarding National Instruments proposal 01/17/23 National Instruments reiterates commitment to strategic review process 01/17/23 National Instruments confirms receipt of acquisition proposal from Emerson 01/17/23 Emerson Electric 'disappointed' National Instruments chose to announce review EMR NATI EMR Emerson Electric $85.55 / +1.77 (+2.11%) 02/21/23 TD Cowen Emerson Electric price target lowered to $105 from $115 at Cowen 02/14/23 Argus Argus cuts Emerson Electric to Hold, sees 'problematic' recent trends 02/14/23 Argus Emerson Electric downgraded to Hold from Buy at Argus 02/09/23 Deutsche Bank Deutsche Bank keeps Hold on Emerson Electric, lowers price target to $93 NATI National Instruments $51.24 / +0.63 (+1.24%) 02/01/23 Baird National Instruments downgraded to Neutral from Outperform at Baird 01/18/23 Baird Aspen Technology price target lowered to $224 from $242 at Baird 01/17/23 Deutsche Bank Emerson makes hostile bid for National Instruments, says Deutsche Bank 01/17/23 Baird National Instruments price target raised to $50 from $46 at Baird NATI EMR NATI National Instruments $51.24 / +0.63 (+1.24%) 01/31/23 National Instruments sees Q1 adjusted EPS 48c-62c, consensus 47c 01/31/23 National Instruments reports Q4 adjusted EPS 63c, consensus 64c 10/27/22 National Instruments sees Q4 non-GAP EPS 54c-68c, consensus 76c 10/27/22 National Instruments reports Q3 non-GAAP EPS 53c, consensus 53c EMR Emerson Electric $85.55 / +1.77 (+2.11%) 02/08/23 Emerson Electric backs FY23 adjusted EPS view $4.00-$4.15, consensus $4.08 02/08/23 Emerson Electric sees Q2 adjusted EPS 95c-$1.00, consensus $1.00 02/08/23 Emerson Electric reports Q1 adjusted EPS 78c, consensus 88c 10/31/22 Emerson Electric sees FY23 adjusted EPS $4.00-$4.15, consensus $5.08 EMR EMR Emerson Electric $85.55 / +1.77 (+2.11%) 10/31/22 Blackstone to buy 55% stake in Emerson unit in $14B deal, WSJ reports 10/04/22 Blackstone in talks to acquire select Emerson assets, Bloomberg says 10/04/22 Blackstone in talks to acquire select Emerson assets, Bloomberg says NATI EMR NATI National Instruments $51.24 / +0.63 (+1.24%) 01/13/23 What You Missed On Wall Street On Friday 01/13/23 What You Missed On Wall Street This Morning EMR Emerson Electric $85.55 / +1.77 (+2.11%) 02/08/23 What You Missed On Wall Street This Morning 02/08/23 Fly Intel: Pre-market Movers 01/17/23 What You Missed On Wall Street On Tuesday 01/17/23 What You Missed On Wall Street This Morning 03/06/23 Technology, Media & Telecom Conference NATI NATI National Instruments $51.24 / +0.63 (+1.24%) 03/01/23 National Instruments call volume above normal and directionally bullish
Options	National Instruments call volume above normal and directionally bullish » 12:25 03/01/23 03/01 12:25 03/01/23 12:25 NATI National Instruments $50.30 / -0.21 (-0.42%) Bullish option flow… Bullish option flow detected in National Instruments with 2,674 calls trading, 2x expected, and implied vol increasing over 3 points to 32.93%. Mar-23 55 calls and Mar-23 47.5 puts are the most active options, with total volume in those strikes near 2,700 contracts. The Put/Call Ratio is 0.38. Earnings are expected on April 27th. ShowHide Related Items >><< Company News Street Research Earnings On The Fly NATI National Instruments $50.30 / -0.21 (-0.42%) 01/23/23 Emerson Electric issues statement regarding National Instruments proposal 01/17/23 National Instruments reiterates commitment to strategic review process 01/17/23 National Instruments confirms receipt of acquisition proposal from Emerson 01/17/23 Emerson Electric 'disappointed' National Instruments chose to announce review NATI National Instruments $50.30 / -0.21 (-0.42%) 02/01/23 Baird National Instruments downgraded to Neutral from Outperform at Baird 01/18/23 Baird Aspen Technology price target lowered to $224 from $242 at Baird 01/17/23 Deutsche Bank Emerson makes hostile bid for National Instruments, says Deutsche Bank 01/17/23 Baird National Instruments price target raised to $50 from $46 at Baird NATI National Instruments $50.30 / -0.21 (-0.42%) 01/31/23 National Instruments sees Q1 adjusted EPS 48c-62c, consensus 47c 01/31/23 National Instruments reports Q4 adjusted EPS 63c, consensus 64c 10/27/22 National Instruments sees Q4 non-GAP EPS 54c-68c, consensus 76c 10/27/22 National Instruments reports Q3 non-GAAP EPS 53c, consensus 53c NATI National Instruments $50.30 / -0.21 (-0.42%) 01/17/23 What You Missed On Wall Street On Tuesday 01/17/23 What You Missed On Wall Street This Morning 01/13/23 What You Missed On Wall Street On Friday 01/13/23 What You Missed On Wall Street This Morning

Over a month ago
Downgrade	National Instruments downgraded to Neutral from Outperform at Baird » 06:32 02/01/23 02/01 06:32 02/01/23 06:32 NATI National Instruments $54.00 / -0.24 (-0.44%) Baird analyst Robert… Baird analyst Robert Mason downgraded National Instruments to Neutral from Outperform with a price target of $55, up from $50. The company's strategic review remains ongoing and Baird's takeout scenario offers a valuation of $52-$57 per share, the analyst tells investors in a research note. The firm believes the stock's risk/reward favors moving to the sidelines. ShowHide Related Items >><< Company News Street Research Earnings On The Fly NATI National Instruments $54.00 / -0.24 (-0.44%) 01/23/23 Emerson Electric issues statement regarding National Instruments proposal 01/17/23 National Instruments reiterates commitment to strategic review process 01/17/23 National Instruments confirms receipt of acquisition proposal from Emerson 01/17/23 Emerson Electric 'disappointed' National Instruments chose to announce review NATI National Instruments $54.00 / -0.24 (-0.44%) 01/18/23 Baird Aspen Technology price target lowered to $224 from $242 at Baird 01/17/23 Deutsche Bank Emerson makes hostile bid for National Instruments, says Deutsche Bank 01/17/23 Baird National Instruments price target raised to $50 from $46 at Baird 12/13/22 Morgan Stanley National Instruments price target raised to $52 from $47 at Morgan Stanley NATI National Instruments $54.00 / -0.24 (-0.44%) 01/31/23 National Instruments sees Q1 adjusted EPS 48c-62c, consensus 47c 01/31/23 National Instruments reports Q4 adjusted EPS 63c, consensus 64c 10/27/22 National Instruments sees Q4 non-GAP EPS 54c-68c, consensus 76c 10/27/22 National Instruments reports Q3 non-GAAP EPS 53c, consensus 53c NATI National Instruments $54.00 / -0.24 (-0.44%) 01/17/23 What You Missed On Wall Street On Tuesday 01/17/23 What You Missed On Wall Street This Morning 01/13/23 What You Missed On Wall Street On Friday 01/13/23 What You Missed On Wall Street This Morning
Earnings	National Instruments sees Q1 adjusted EPS 48c-62c, consensus 47c » 16:08 01/31/23 01/31 16:08 01/31/23 16:08 NATI National Instruments $54.00 / -0.24 (-0.44%) Sees Q1 revenue… Sees Q1 revenue $415M-$445M, consensus $419.59M. ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events NATI National Instruments $54.00 / -0.24 (-0.44%) 01/23/23 Emerson Electric issues statement regarding National Instruments proposal 01/17/23 National Instruments reiterates commitment to strategic review process 01/17/23 National Instruments confirms receipt of acquisition proposal from Emerson 01/17/23 Emerson Electric 'disappointed' National Instruments chose to announce review NATI National Instruments $54.00 / -0.24 (-0.44%) 01/18/23 Baird Aspen Technology price target lowered to $224 from $242 at Baird 01/17/23 Deutsche Bank Emerson makes hostile bid for National Instruments, says Deutsche Bank 01/17/23 Baird National Instruments price target raised to $50 from $46 at Baird 12/13/22 Morgan Stanley National Instruments price target raised to $52 from $47 at Morgan Stanley NATI National Instruments $54.00 / -0.24 (-0.44%) 01/31/23 National Instruments reports Q4 adjusted EPS 63c, consensus 64c 10/27/22 National Instruments sees Q4 non-GAP EPS 54c-68c, consensus 76c 10/27/22 National Instruments reports Q3 non-GAAP EPS 53c, consensus 53c NATI National Instruments $54.00 / -0.24 (-0.44%) 01/17/23 What You Missed On Wall Street On Tuesday 01/17/23 What You Missed On Wall Street This Morning 01/13/23 What You Missed On Wall Street On Friday 01/13/23 What You Missed On Wall Street This Morning 01/31/23 National Instruments - NATI
Earnings	National Instruments reports Q4 adjusted EPS 63c, consensus 64c » 16:07 01/31/23 01/31 16:07 01/31/23 16:07 NATI National Instruments $54.01 / -0.23 (-0.42%) Reports Q4 revenue… Reports Q4 revenue $448.28M, consensus $453.89M. "2022 was a strong year as we continued to make strides in transforming NI into a higher-growth, more profitable, and more resilient company. Despite ongoing global macroeconomic uncertainty, we delivered on the 2022 targets we shared at our September investor conference with record revenue of $1.7 billion, up 13 percent YOY, and non-GAAP operating margin of 20 percent, up 130 bps as compared to 2021," said Eric Starkloff, NI president and CEO. "As we head into 2023, even in a recessionary environment, we now expect to exceed our 300 bps non-GAAP margin expansion target." ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events NATI National Instruments $54.01 / -0.23 (-0.42%) 01/23/23 Emerson Electric issues statement regarding National Instruments proposal 01/17/23 National Instruments reiterates commitment to strategic review process 01/17/23 National Instruments confirms receipt of acquisition proposal from Emerson 01/17/23 Emerson Electric 'disappointed' National Instruments chose to announce review NATI National Instruments $54.01 / -0.23 (-0.42%) 01/18/23 Baird Aspen Technology price target lowered to $224 from $242 at Baird 01/17/23 Deutsche Bank Emerson makes hostile bid for National Instruments, says Deutsche Bank 01/17/23 Baird National Instruments price target raised to $50 from $46 at Baird 12/13/22 Morgan Stanley National Instruments price target raised to $52 from $47 at Morgan Stanley NATI National Instruments $54.01 / -0.23 (-0.42%) 10/27/22 National Instruments sees Q4 non-GAP EPS 54c-68c, consensus 76c 10/27/22 National Instruments reports Q3 non-GAAP EPS 53c, consensus 53c NATI National Instruments $54.01 / -0.23 (-0.42%) 01/17/23 What You Missed On Wall Street On Tuesday 01/17/23 What You Missed On Wall Street This Morning 01/13/23 What You Missed On Wall Street On Friday 01/13/23 What You Missed On Wall Street This Morning 01/31/23 National Instruments - NATI
Hot Stocks	Emerson Electric issues statement regarding National Instruments proposal » 07:00 01/23/23 01/23 07:00 01/23/23 07:00 EMR Emerson Electric $87.35 / +0.475 (+0.55%) , NATI National Instruments $54.23 / +0.47 (+0.87%) Emerson (EMR) issued the… Emerson (EMR) issued the following statement regarding its all-cash proposal to acquire National Instruments (NATI) for $53 per share: "Emerson's objective with publicly disclosing our proposal to acquire NI was to ensure that the NI Board of Directors executed a fair and transparent strategic review process, and that NI's shareholders understood the credibility of our proposal. Over the course of the last week, following the public statements by Emerson and NI, we have been pleased to see engagement between the management teams and advisors for NI and Emerson. We are optimistic that the NI Board has commenced a process that we believe will lead to the sale of the company. NI has also confirmed Emerson will be a participant in that process. With the steps that NI and its Board have taken since our public proposal, Emerson has decided to proceed in its pursuit of acquiring NI without nominating its selected Independent Directors for election to NI's Board at its upcoming Annual Meeting of Stockholders. Emerson is committed to an acquisition of NI and is participating in the strategic review process. We believe our premium all-cash proposal at $53 a share, with no financing conditions or anticipated regulatory concerns, is compelling and in the best interest of Emerson and NI shareholders. We look forward to continued engagement with NI and its advisors and moving swiftly towards an agreed transaction." ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events EMR EMR Emerson Electric $87.35 / +0.475 (+0.55%) 01/17/23 National Instruments reiterates commitment to strategic review process 01/17/23 National Instruments confirms receipt of acquisition proposal from Emerson 01/17/23 Emerson Electric 'disappointed' National Instruments chose to announce review 01/17/23 Emerson says National Instruments resisted 'engaging meaningfully' on offer EMR NATI EMR Emerson Electric $87.35 / +0.475 (+0.55%) 01/18/23 Baird Aspen Technology price target lowered to $224 from $242 at Baird 01/17/23 Deutsche Bank Emerson makes hostile bid for National Instruments, says Deutsche Bank 01/09/23 Citi Citi opens 'positive 90-day catalyst watch' on Rockwell Automation 01/04/23 UBS Emerson Electric downgraded to Neutral from Buy at UBS NATI National Instruments $54.23 / +0.47 (+0.87%) 01/17/23 Baird National Instruments price target raised to $50 from $46 at Baird 12/13/22 Morgan Stanley National Instruments price target raised to $52 from $47 at Morgan Stanley NATI EMR NATI National Instruments $54.23 / +0.47 (+0.87%) 10/27/22 National Instruments sees Q4 non-GAP EPS 54c-68c, consensus 76c 10/27/22 National Instruments reports Q3 non-GAAP EPS 53c, consensus 53c 07/28/22 National Instruments reaffirms guidance for full year 2022 07/28/22 National Instruments sees Q3 EPS 46c-60c, consensus 54c EMR Emerson Electric $87.35 / +0.475 (+0.55%) 10/31/22 Emerson Electric sees FY23 adjusted EPS $4.00-$4.15, consensus $5.08 10/31/22 Emerson Electric sees Q1 adjusted EPS 85c-89c, consensus $1.21 10/31/22 Emerson Electric reports Q4 adjusted EPS $1.53, consensus $1.38 08/09/22 Emerson Electric raises FY22 adjusted EPS view to $5.05-$5.15 from $4.95-$5.10 EMR EMR Emerson Electric $87.35 / +0.475 (+0.55%) 10/31/22 Blackstone to buy 55% stake in Emerson unit in $14B deal, WSJ reports 10/04/22 Blackstone in talks to acquire select Emerson assets, Bloomberg says 10/04/22 Blackstone in talks to acquire select Emerson assets, Bloomberg says NATI EMR NATI National Instruments $54.23 / +0.47 (+0.87%) 01/13/23 What You Missed On Wall Street On Friday 01/13/23 What You Missed On Wall Street This Morning EMR Emerson Electric $87.35 / +0.475 (+0.55%) 01/17/23 What You Missed On Wall Street On Tuesday 01/17/23 What You Missed On Wall Street This Morning 01/04/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 10/31/22 What You Missed On Wall Street On Monday 01/31/23 National Instruments - NATI 02/08/23 Emerson Electric - EMR 02/07/23 Emerson Electric Co.

Get Full Fly Access

Breaking market intelligence sent straight to you: Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.

Up-to-date information on important industry events: Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.

News focused on the companies in your portfolio: Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.

14 Day Free Trial